Here Is the Complete 2026 List and What to Do
UK Sertraline Recall (April 2026) | US Duloxetine, Sertraline & Clomipramine Recalls | Nitrosamine Risks | Full Patient Guide
Two Separate Crises — One Complete Guide
You have just a very good chance of seeing a headline in the last 48 hours that made your stomach drop, should you take antidepressants. And there actually are two separate stories that crunch at the same time one in the UK and one in the US- they are all directly related to millions of people who use these medications on an everyday basis.
On April 28, 2026, MHRA issued a Class 2 recall of 81,872 packs of Sertraline 100mg on the basis that one of the patients had discovered citalopram tablets in their sealed sertraline carton, a manufacturing packaging error by Amarox Limited.
In the US, a much wider scope of antidepressant recall crisis has been being managed by the FDA since late 2024, with over 233,000 bottles of duloxetine (Cymbalta) recalled at its peak and with multiple recalls of generic antidepressants sertraline, clomipramine, and others, due to elevated levels of cancer-linked nitrosamine chemical impurities.
And now, before we proceed any further–and this is the most important thing in this whole article–do not discontinue taking your antidepressant. Both the MHRA and FDA make it clear that the potential risk of stopping antidepressant treatment abruptly is almost always greater than the potential risk of the recall itself. Check your medication. Contact your pharmacist. But do not stop.
Here we discuss the two recalls in detail: what happened, which drugs are involved, the complete reference table, what the risks really are, and what you need to do today.
URGENT — Check Your Medication Right Now
UK: Sertraline 100mg batch V2500425 (Amarox) recalled April 28, 2026 — wrong drug found inside packs. Check your batch number on the outer carton. | US: Multiple antidepressants recalled 2024–2026 for cancer-linked nitrosamine impurities — duloxetine, sertraline, clomipramine affected. | DO NOT STOP your antidepressant without speaking to your doctor first — abrupt discontinuation is dangerous. Call NHS 111 (UK) or contact your pharmacist (US) for guidance.
Table of Contents
The UK Sertraline Recall — April 28, 2026
Recalled Batch — UK Only
Product: Sertraline 100mg film-coated tablets | Manufacturer: Amarox Limited | Batch Number: V2500425 | Classification: Class 2 (MHRA) | Packs Recalled: 81,872 | How to check: Look at the side of your outer carton for the batch number.
A patient in the UK opened his sealed prescription pack and found something amiss, the strip of blisters in his sertraline 100mg carton was marked citalopram 40mg. The MHRA was notified of it by that patient. Due to the attention of one patient, 81,872 packs were recalled.
The manufacturing defect was in secondary packaging – the process whereby the blister strips of tablets are inserted into their outer cartons. Amarox Limited manufactures sertraline and citalopram in the same facility. In one run of packaging, blister strips of citalopram were put in the wrong cartons of sertraline. The batch was initially issued on November 28, 2025.
What to Do If You Have Batch V2500425
- Locate your sertraline 100mg outer carton and find the batch number printed on the side or back.
- When your batch number is not V2500425 – you will not be affected, proceed with your medication as usual.
- Provided your batch number = V2500425 – open the carton and examine the label on the blister strip inside.
- When the blister strip indicates that it contains Sertraline, 100mg- the correct drug is present, no action required.
- When the blister strip reads Citalopram 40mg – do not take the tablets and contact your pharmacy to be supplied with another one.
- Did you already take some of the tablets in this batch? -read the symptoms section below and call NHS 111 or your GP.
The Chief Safety Officer of the MHRA Dr Alison Cave confirmed that those patients who accidentally took citalopram rather than sertraline may experience increased serotonergic effects such as nausea, headache, sleep changes, and mild anxiety. There was one negative experience of headache, which was solved with the help of termination. Some patients require increased attention: patients older than 65 or younger than 18, patients with heart disorders (the dose-response effect of citalopram 40mg on heart rate), and patients with liver diseases.
The US Antidepressant Recall Wave — 2024 to 2026
The US situation is structurally different and much broader. It is not about packaging errors – it is about chemical contamination during the manufacturing process itself. The main problem is the nitrosamine impurities a group of chemical compounds which, in high concentrations and long-lasting effects, are associated with the risk of cancer.
What started as a one-time drug recall of blood pressure drugs in 2018 has evolved into the largest drug safety crisis in the history of pharmaceuticals. In excess of 500 FDA recalls have been issued to levels of nitrosamine which surpass safety levels – and antidepressants have been directly caught up in this crisis since 2024.
Duloxetine (Cymbalta) — The Most Recalled Antidepressant
Duloxetine is an SNRI antidepressant (Cymbalta) used in the treatment of depression, anxiety and chronic pain, and has been the subject of several large scale recalls. In December 2024 Breckenridge Pharmaceuticals recalled more than 233,000 bottles because of the occurrence of N-nitroso-duloxetine exceeding FDA-recommended interim limits. This was on top of a recall by the same reason of 7,107 bottles in October 2024. Another recall of 12 242 bottles followed in July 2025 – the same company, the same contamination problem.
N-nitroso-duloxetine is a nitrosamine-specific drug that has the potential to form in the manufacturing or storage process. Each recall was classified by FDA as Class II -the same as precautionary recall-meaning that there may be temporary or medically reversible health effects, but serious health effects are considered unlikely at the levels of exposure involved.
Sertraline and Clomipramine — US Recalls
Sertraline was also the subject of US recalls in 2025. Lupin Pharmaceuticals recalled several lots of sertraline hydrochloride 100mg due to quality control problems. In September 2025, Rising Pharma recalled 46,512 bottles of sertraline 300mg due to failed tests on tablet specifications. These are not connected or related to the UK packaging error recall.
Both Heritage Pharmaceuticals (Avet), and Zydus Pharmaceuticals recalled clomipramine, a tricyclic antidepressant used in OCD and treatment-resistant depression, in October 2025, with a total of 33,000+ bottles recalled due to nitrosamine impurities exceeding FDA limits.
Complete Antidepressant Recall Reference — 2024 to 2026
This table will help you determine whether or not your medication has been affected. Always cross-check your particular lot or batch number with the official FDA or MHRA recall notices:
| Drug / Country | Recall Reason | Scale | Action |
| Sertraline 100mg (UK — Amarox) | Wrong drug (citalopram) in packaging | 81,872 packs Batch V2500425 | Check batch number; contact pharmacy if affected |
| Duloxetine 40mg (US — Breckenridge/Towa) | Nitrosamine above FDA limit | 12,242 bottles July 2025 | Check lot; consult pharmacist |
| Duloxetine multiple (US — Breckenridge) | N-nitroso-duloxetine above limit | 343,000+ bottles April 2025 | Check lot; do not stop medication |
| Duloxetine 30/90-ct (US — Breckenridge) | N-nitroso-duloxetine above limit | 233,000+ bottles Dec 2024 | Consult pharmacist about alternatives |
| Sertraline 100mg (US — Lupin) | Quality control failure | Multiple lots 2025 | Check lot number; consult pharmacist |
| Sertraline 300mg (US — Rising Pharma) | Failed tablet specification | 46,512 bottles Sept 2025 | Check lot number |
| Clomipramine (US — Avet/Heritage) | Nitrosamine impurity above FDA limit | 33,663 bottles Oct 2025 | Check lot; consult prescriber |
| Clomipramine capsules (US — Zydus) | Nitrosamine impurity above FDA limit | Quantity unspecified Oct 2025 | Check lot number |
What Is a Nitrosamine — and Is It Actually Dangerous?
Nitrosamines are chemical substances that are formed when certain molecules interact under heat, pressure or conditions of storage. The most notorious, namely NDMA and NDEA are recognised carcinogens, i.e. they can cause cancer at high doses over prolonged periods. Nitrosamines that are drug-specific, such as N- nitroso-duloxetine, act in a similar way.
The critical context: the FDA points out that when a person consumes a drug containing nitrosamines in the amount of no more than the acceptable daily intake, then every day over a period of 70 years will not be expected to increase the risk of cancer. The reason behind the triggering of recalls is because levels which EXCEED such levels trigger recalls, rather than any detectable presence being hazardous.
Nitrosamines are present in common food stuff such cured and grilled meat, dairy products and even water. The small amounts of these are processed by the body in routine without any damage. The drug safety issue is protracted exposure to amounts greater than the established safe amount – which is measured in nanograms, amounts far less than those that are visible.
Why Is This Happening to So Many Drugs?
Nitrosamines may be formed by simple chemical reactions in drug production, by reactions between drug ingredients or in storing. The issue is funnelled in the generic drug production – most of them located in India and Spain. In 2023, the FDA issued detailed guidance that requires advanced testing methods, but due to the scale of the problem, involving hundreds of generic manufacturers, full compliance is a process that will take years. It is a continuing systemic quality control concern, not a conspiracy, or an abrupt safety malfunction.
The Most Important Warning — Do NOT Stop Suddenly
Critical Patient Safety Message
Both the FDA and MHRA directly inform its users that it is not advisable to discontinue taking recalled antidepressants unless you first discuss it with your healthcare provider. The discontinuation syndrome is well documented and may be severe and dangerous, especially in vulnerable patients, as a result of abrupt discontinuation of SSRIs and SNRIs. In case your medicine is included in the recall list, then get in touch with your pharmacist to get another lot. Do not simply stop.
SSRI and SNRI discontinuation syndrome – the group of symptoms that occur when medications used in mental health therapy are abruptly stopped – is also one of the most under-recognised risks in the management of medications used in mental health treatment. They may onset between 24-48 hours after the last dose, and include electric shock-like sensations through the head and body (brain zaps), extreme dizziness, intense nausea, extreme rebound anxiety, irritability, mood fluctuations, and in susceptible patients- a lethal increase in suicidal ideation.
The risk of continuing to take a recalled medication over a few more days as you prepare to get a replacement is in virtually every known case, significantly less than the risk of abruptly discontinuing. Pharmacists are in a position to get alternative lots of different manufacturers instantly. In case of an emergency, your GP can provide you with an emergency prescription which can be filled on the same day (under a time constraint).
How to Check If Your Specific Medication Is Recalled
UK Patients — MHRA
- Visit: gov.uk/drug-device-alerts — searchable database of all active alerts and recalls of drugs and devices in the UK.
- Check the batch or lot number on your outer packaging with the current recall notices.
- Contact your pharmacy – they must have identified affected patients, and will make replacements.
- Any questions about medication safety: Call NHS 111 (24/7) on any concerns.
- Disclose adverse effects through the MHRA Yellow Card scheme: yellowcard.mhra.gov.uk.
US Patients — FDA
- Visit: fda.gov/drugs/drug-safety-and-availability/drug-recalls – search by drug name.
- Check your lot number with the recall notice of a particular lot number – lot numbers are printed on the bottle label.
- Contact your pharmacist – he or she can look up the latest information on the recall, and can verify your particular lot.
- Reporting: through FDA MedWatch: fda.gov/safety/medwatch.
- Do not dispose of a recalled medication without the advice of a pharmacist – take it back to the pharmacy.
Frequently Asked Questions
Q: Which antidepressants have been recalled in 2025–2026?
Sertraline 100mg batch V2500425 (Amarox Limited) was a recalled drug in the UK, after the package containing the drug was found to have the wrong drug. In the US, the most notable recalls have been of duloxetine (Cymbalta) by Breckenridge Pharmaceuticals – more than 233,000 bottles recalled in December 2024 – as well as generic sertraline by Lupin, and Rising Pharma, and clomipramine by Avet/Heritage and Zydus, all of which will be affected by the contamination of nitrosamine impurities in 2025.
Q: Should I stop taking my antidepressant because of the recall?
No – not without having a word with your physician or pharmacist. Both the MHRA and FDA clearly recommend against abrupt discontinuation of antidepressants due to a recall. The risk of abrupt discontinuation (including severe withdrawal symptoms, mood instability) is usually more significant than the risk of continued use of a recalled drug. Get in touch with your pharmacist to obtain a new lot and keep doing your prescribed dosage until you are safely switched.
Q: What is the sertraline recall batch number in the UK?
The batch recalled is V2500425 – Sertraline 100mg film-coated tablets manufactured by Amarox Limited, recalled April 28, 2026. This batch number may be found on the side of your outside carton. In case your pack has another batch number, then you are not affected by this particular recall and are free to continue taking your medication as usual.
Q: What is a nitrosamine and why is it in antidepressants?
Nitrosamines are chemical substances which may be formed during the production of drugs when some components interact with a heat or pressure. They are also able to form during storage. Nitrosamines of a drug, such as N-nitroso-duloxetine are formed by the reaction of the drug molecule with contaminants during manufacturing. They are linked to a higher risk of cancer when exposed to a high level of exposure in the long term -but FDA says that cancer risk does not increase with exposure to an amount of exposure that is within acceptable daily intake limits over a lifetime.
Q: Are all antidepressants being recalled?
No. It is only particular lots or batches of certain manufacturers that are recalled. All the antidepressant prescriptions filled out in the UK as well as in the US are totally unaffected. Recalling a single batch or lot of a drug does not imply that the whole drug is dangerous, but means that one of the production runs did not meet quality standards. Your pharmacist would be able to confirm whether or not a particular product is in an affected lot.
Conclusion — Check, Contact, Continue
In 2026, two parallel stories are being run about the recall of antidepressants. Both are real. Both require attention. Neither requires panic.
When you are in the UK and take Sertraline 100mg – check your batch number. Assuming that it is V2500425, one should check the blister strip inside. Provided that it demonstrates citalopram, call your pharmacy. In case it indicates sertraline, proceed.
In case you are in the US and are taking duloxetine, sertraline, or clomipramine – check the lot number on the FDA recall database, or ask your pharmacist to do that on your behalf. Pharmacists deal with recalls at all times, and will have a replacement at hand at all times should the need arise.
In all instances: the correct action is to verify your medicine, communicate to your pharmacist and proceed with your treatment safely under medical advice. Do not discontinue an antidepressant due to a newspaper headline. And that is just what your prescriber is there to guide you.
Medical Disclaimer
This article is for informational purposes only. Always consult your pharmacist, GP, or call NHS 111 before making any changes to prescribed medication. Do not stop antidepressants without medical guidance.